Search results
4 days ago · Sidney Kimmel founded apparel company Jones Group more than four decades ago; it owned brands including Stuart Weitzman and Nine West. In 2014, he sold the company for $2.2 billion to private...
21 hours ago · Executive producers are Walker, Sidney Kimmel, Brian Kornreich, Jo Henriquez, Scott Ratner, Amani King and Angus Wall, according to a news release. The documentary is premiering on Netflix after playing as a work in progress in 2023 at the Toronto International Film Festival and screening earlier this year at the San Francisco International Film Festival and the Mountainfilm Festival in Telluride, Colorado.
1 day ago · According to the Sidney Kimmel Foundation, which pledged $70 million to Thomas Jefferson University for construction, the facility is named in honor of Mr. Kimmel’s and “will anchor the university’s Locust Street research corridor, markedly expand Jefferson’s research capacity, and facilitate interdisciplinary collaborations within the Sidney Kimmel Cancer Center and the Jefferson research community at large.”
2 days ago · He eventually convinced businessman Sidney Kimmel's company to finance the script. Shortly after that happened, his daughter was kidnapped in real life, giving him a deeper personal connection to the story he wanted to make into a movie.
3 days ago · Jefferson Health's Sidney Kimmel Cancer Center was recently named as Comprehensive by the National Cancer Institute. Only 2% of cancer centers have this status nationwide! And we have it right ...
21 hours ago · About Joli C. Chou, DMD, MD, FACS: Dr. Joli C. Chou is an Associate Professor in the Department of Oral and Maxillofacial Surgery at Thomas Jefferson University Sidney Kimmel Medical College. She is a graduate of the University of Pennsylvania School of Medicine and Tufts University School of Dental Medicine.
5 days ago · One active clinical trial examining the treatment of stage I-III Malignant Pleural Mesothelioma is being conducted in Baltimore, Maryland, at the University of Maryland/Greenbaum Cancer Center and Johns Hopkins University/Sidney Kimmel Cancer Center. The trial is examining how nivolumab, with or without ipilimumab, affects people suffering from stages I-III malignant pleural mesothelioma.
